
Please try another search
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company’s preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.
Name | Age | Since | Title |
---|---|---|---|
Vicki L. Sato | 75 | 2016 | Independent Chairman |
Marianne De Backer | 55 | 2023 | CEO & Director |
Robert Taylor Nelsen | 63 | 2016 | Independent Director |
George A. Scangos | 77 | 2017 | Director |
Charles M. Rice | - | - | Scientific Advisor |
Susanna Naggie | - | - | Scientific Advisor |
Jeffrey A. Bluestone | 72 | - | Scientific Advisor |
Thomas O. Daniel | 71 | 2017 | Scientific Advisor |
George H. Poste | 81 | - | Scientific Advisor |
Francis V. Chisari | - | - | Scientific Advisor |
Jeffrey V. Ravetch | 74 | - | Scientific Advisor |
Emilio A. Emini | 72 | 2015 | Scientific Advisor |
Sona Saira Gonsalves Ramasastry | 49 | 2019 | Independent Director |
Jeffrey S. Hatfield | 67 | 2020 | Independent Director |
Robert J. More | 57 | 2016 | Independent Director |
Charles Elliott Sigal | 73 | 2020 | Independent Director |
Janet Napolitano | 67 | 2020 | Independent Director |
Norbert W. Bischofberger | 69 | 2024 | Independent Director |
Ramy Farid | 60 | 2024 | Independent Director |
Louis J. Picker | - | - | Co-Founder & Scientific Advisor |
Lawrence Corey | 77 | 2016 | Co-Founder & Scientific Advisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review